Source: International Congress 2017 – Open questions in pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Sitbon (Le Kremlin-Bicêtre, France). Different treatment modalities in chronic thromboembolic pulmonary hypertension: how to combine them?. International Congress 2017 – Open questions in pulmonary vascular diseases

Member's Comments

No comment yet.

Related content which might interest you: Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options Source: Eur Respir Rev 2009; 18: 24-28 Year: 2009 Chronic thromboembolic pulmonary hypertension: do we need a new definition? Source: Eur Respir J 2014; 44: 1401-1403 Year: 2014 Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape Source: Eur Respir Rev 2015; 24: 173-177 Year: 2015 Surgical treatment of chronic thromboembolic pulmonary hypertension: a single centre experience Source: Eur Respir J 2001; 18: Suppl. 33, 14s Year: 2001 Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension? Source: Eur Respir J 2014; 44: 842-845 Year: 2014 Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2015; 24: 272-282 Year: 2015 A roadmap for management of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019 Year: 2019 The changing landscape of chronic thromboembolic pulmonary hypertension management Source: Eur Respir Rev, 26 (146) 170105; 10.1183/16000617.0105-2017 Year: 2017 Chronic thromboembolic pulmonary hypertension and splenectomy: Is there a link? Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003 Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease Source: Annual Congress 2004 - Treatment of pulmonary hypertension Year: 2004 Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012 Sequential multimodal therapy in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Chronic post-embolic pulmonary hypertension: a new target for medical therapies?}, Source: Eur Respir Rev 2013; 22: 258-264 Year: 2013 Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020 Year: 2020 Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018 Survival in patients with chronic thromboembolic pulmonary hypertension in the modern management era Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Newly diagnosed patients with chronic thromboembolic pulmonary hypertension and PASP<50 mmHg. Do they need pulmonary endarterectomy? Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Real-life data on the medical therapy of pulmonary arterial and chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – PAH and CTEPH Year: 2017